Special Issue "Marine Skeletal Biopolymers and Proteins, and Their Biomedical Application"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: 15 July 2020.
2: Center for Climate Change Research, Toronto, Ontario, Canada
Interests: marine biology; marine proteins; corals; marine collagen; marine chitin; marine polysaccharides; drug discovery; biomineralization; marine biomaterials; marine invertebrates; marine algae; proteomics; marine Biotechnology
Special Issues and Collections in MDPI journals
Marine skeletal proteins and biopolymers have a great potential application in the medical field. The skeletal biopolymers include chitin and chitosan, collagen, cellulose, and various polysaccharides. The marine skeletal proteins, for instance, calcium-binding proteins, marine enzymes, and various candidate proteins for drug discovery from the calcifying marine organisms. Due to their broad spectrum of biological functions into biopolymer and protein-based drugs and bioactivities, such as anticancer, antimicrobial, bone tissue regeneration, antioxidant, and anti-aging activities, bioactive skeletal proteins and biopolymer have recently gained a great amount of interest in the pharmaceutical, nutraceutical, and cosmeceutical industries. Marine skeletal proteins are also a very rich source of amino acids, which are essential for building good health.
Researchers around the world have found that the biopolymers, proteins, and peptides extracted from marine calcifiers are the most convenient and safest sources. The advantages of this source are the huge availability and abundance in the shallow, mid-level, and deep-sea waters. This source includes marine invertebrates and related calcifiers, for example, soft and hard corals, mollusks/bivalves, sponges, sea urchins, coralline red algae, and other calcifying marine organisms.Dr. Azizur Rahman
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Marine proteins and peptides
- Sea urchins
- Marine algae
- Marine Collagen
- Marine Chitin
- Marine polysaccharides
- Marine bioactive compounds
- Marine Biotechnology
- Marine biomaterials